BamSEC and AlphaSense Join Forces
Learn More

Channel Therapeutics Corporation

NYSE American: CHRO    
Share price (12/24/24): $0.63    
Market cap (12/24/24): $3.805 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1II
from 8-K12G3 12 pages Bylaws of Channel Therapeutics Corporation, a Nevada Corporation
12/34/56
EX-3.1IC
from 8-K12G3 14 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Channel Therapeutics Corporation Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1IB
from 8-K12G3 2 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.1IA
from 8-K12G3 17 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.1II
from 8-K 12 pages Bylaws of Channel Therapeutics Corporation, a Nevada Corporation
12/34/56
EX-3.1IC
from 8-K 14 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Channel Therapeutics Corporation Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1IB
from 8-K 2 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.1IA
from 8-K 17 pages Respectfully, Francisco V. Aguilar Secretary of State Page 1 of 1 Commercial Recording Division 401 N. Carson Street
12/34/56
EX-3.3
from 10-K 13 pages Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.2
from 8-K 24 pages Amended and Restated By-Laws of Chromocell Therapeutics Corporation
12/34/56
EX-3.1
from 8-K 8 pages Amended and Restated Certificate Incorporation of Chromocell Therapeutics Corporation I
12/34/56
EX-3.5
from S-1/A 12 pages Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.4
from S-1/A 29 pages Certificate of Designations, Preferences and Rights of the Series B Convertible Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.5
from S-1/A 13 pages Certificate of Designation of Series C Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.4
from S-1/A 29 pages Certificate of Designations, Preferences and Rights of the Series B Convertible Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.4
from S-1/A 13 pages Certificate of Designation of Series B Convertible Redeemable Preferred Stock of Chromocell Therapeutics Corporation
12/34/56
EX-3.5
from S-1/A 24 pages Amended and Restated By-Laws of Chromocell Therapeutics Corporation
12/34/56
EX-3.4
from S-1/A 22 pages Bylaws of Chromocell Therapeutics Corporation a Delaware Corporation
12/34/56
EX-3.3
from S-1/A 8 pages Amended and Restated Certificate Incorporation of Chromocell Therapeutics Corporation I
12/34/56
EX-3.2
from S-1/A 6 pages Certificate of Designation of Series a Convertible Preferred Stock of Chromocell Therapeutics Corporation
12/34/56